Back to results
TerminatedPhase 2

Valproic Acid in Combination With FEC100 for Primary Therapy in Patients With Breast Cancer

NCT01010854

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

University of California San Francisco

San Francisco, California, United States

View on ClinicalTrials.gov
Valproic Acid in Combination With FEC100 for Primary Therapy in Patients With Breast Cancer — TrialFind